The Latest Breaking News from Moderna

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease symptoms and duration, according to an animal study published in the journal Cell on Wednesday.

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

FDA-approved updated COVID-19 vaccines crucial for protection against new strains. Get vaccinated promptly to safeguard public health.

The FDA approved updated COVID-19 vaccines for the 2024-25 season, preparing for an expected spike in cases this fall and winter. 

Ready or not, back-to-school season is here, and kids will be bringing home more than homework. They’ll be carrying germs, too.

Job seekers need to hone a personal brand, upskill themselves, and stay resilient.

Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

As part of the Biden admin's pandemic preparedness strategy, Moderna will develop an mRNA vaccine for H5N1